ArticleArthritis research & therapy2011

Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.

Diana Carmona-Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.